| |
|
|
|
vTv Therapeutics Inc.  
|
|
1.55 0.175 (0.13%) |
07-16 16:00 |
|
Open: |
1.46 |
Pre close: |
1.375 |
Target:
|
1.96 
|
|
High: |
1.68 |
Low: |
1.45 |
Resistance:
|
1.68
1.96
|
|
Volume: |
1,823,266 |
Market Cap: |
84M |
Support:
|
1.41
1.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.43
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.41 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
1.64  |
Stochastic Oscillator |
%K(14,3):
|
37.39 |
|
MA(250): |
1.85 |
%D(3): |
38.11 |
|
Average Volume(K) |
3-Month: |
83227
|
52-Week |
High:
|
6.09 |
|
10-Days: |
45801 |
Low: |
0.68 |
|
RSI |
RSI(14):
|
57.32 |
Change(%): |
4.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.736 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
9.69 |
|
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-73.5 |
Shares Float (M) |
9.34 |
|
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
69.32 |
|
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
-55.4 |
% Held by Institutions |
2.20 |
|
Forward EPS |
-1.728 |
Gross Profit (p.s.) |
-1.094 |
Shares Short (K) |
1590 |
|
Book Value (p.s.) |
-2.120 |
EBITDA (p.s.) |
-1.526 |
P/E |
-2.08 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-0.72 |
|
Profit Margin |
-63.01 |
Operating Cash Flow
(M) |
-26.91 |
P/S |
20591248.00 |
|
Operating Margin |
-132.64 |
Levered Free Cash Flow
(M) |
-20.88 |
P/CF |
-0.55 |
|
|
|
|
|
|
